Clearmind Medicine receives nod for delisting of shares from Canadian Securities Exchange
Clearmind Medicine (NASDAQ:CMND) Wednesday announced that it received approval for a voluntary delisting of its common shares from the Canadian Securities Exchange.
The delisting...
Clearmind Medicine Brief: Says Received Approval for a Voluntary Delisting of its Common Shares From the Canadian Securities Exchange -March 13, 2024 at 10:17...
Clearmind Medicine Inc. is a Canada-based psychedelic pharmaceutical biotech company. The Company is focused on the...
Canada Household Debt Levels Ease for Third Straight Quarter
By Robb M. Stewart
OTTAWA--Household debt in Canada continued to fall in the final quarter of last year as...
Stock Rally Buoys Canada Household Net Worth, Housing Drags
(Bloomberg) -- A global rally in bonds and equities supported Canadians’ wealth at the end of last year, offsetting continued declines in real estate...
TSX Today: What to Watch for in Stocks on Wednesday, March 13
The Canadian equities market continued to rise for a second consecutive session on Tuesday, despite the release of slightly hotter-than-expected U.S. consumer inflation...
